Previous studies have demonstrated that good adherence to insulin therapy is an essential requirement for achieving adequate glycemic control and subsequently slowing the progression of microvascular and macrovascular complications, which are mostly associated with DM [2, 28]. The gene discussed is INS; the disease is diabetes mellitus.